BI 1060469 TF1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 1060469 TF1, covering 2015-09-24 to 2015-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects [Phase 1]